Trials / Unknown
UnknownNCT00097734
Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis
A Prospective, Multicenter, Open-Label, Randomized Clinical Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 540 (planned)
- Sponsor
- Klinikum Hanover-Siloah Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy (by assessing the clinical success of treatment) of intravenous antibiotic therapy with ertapenem in patients with acute attacks of sigmoid diverticulitis for 4 vs. 7 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ertapenem |
Timeline
- Start date
- 2004-07-01
- Completion
- 2007-06-01
- First posted
- 2004-11-30
- Last updated
- 2006-02-14
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00097734. Inclusion in this directory is not an endorsement.